Cargando…
A Trivalent Enzymatic System for Uricolytic Therapy of HPRT Deficiency and Lesch-Nyhan Disease
PURPOSE: Because of the evolutionary loss of the uricolytic pathway, humans accumulate poorly soluble urate as the final product of purine catabolism. Restoration of uricolysis through enzyme therapy is a promising treatment for severe hyperuricemia caused by deficiency of hypoxanthine-guanine phosp...
Autores principales: | Ronda, Luca, Marchetti, Marialaura, Piano, Riccardo, Liuzzi, Anastasia, Corsini, Romina, Percudani, Riccardo, Bettati, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445154/ https://www.ncbi.nlm.nih.gov/pubmed/28508122 http://dx.doi.org/10.1007/s11095-017-2167-6 |
Ejemplares similares
-
Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome
por: Torres, Rosa J, et al.
Publicado: (2007) -
Molecular analysis of hypoxanthine guanine phosphoribosyltransferase (HPRT) gene in five Korean families with Lesch-Nyhan syndrome.
por: Kim, K. J., et al.
Publicado: (1997) -
The renal phenotype of allopurinol-treated HPRT-deficient mouse
por: Zennaro, Cristina, et al.
Publicado: (2017) -
HPRT-Deficiency Dysregulates cAMP-PKA Signaling and Phosphodiesterase 10A Expression: Mechanistic Insight and Potential Target for Lesch-Nyhan Disease?
por: Guibinga, Ghiabe-Henri, et al.
Publicado: (2013) -
Dopamine function in Lesch-Nyhan disease.
por: Nyhan, W L
Publicado: (2000)